Semax is primarily degraded by aminopeptidases and endopeptidases in serum and brain tissue, with cleavage occurring at multiple sites along the peptide chain. N-terminal degradation is most rapid, which is why N-acetyl modifications significantly extend half-life.
Metabolic stability studies identify specific peptidase enzymes responsible for Semax degradation and inform strategies for structural optimization.